Taysha Gene Therapies Inc. Gains 97.35%

Tue, Oct 25, 2022 at 07:33 PM
Taysha Gene Therapies Inc. Gains 97.35%

Taysha Gene Therapies Inc. (TSHA:NASDAQ) rocketted at $2.98, representing a gain of 97.4%. On Tue, Oct 25, 2022, TSHA:NASDAQ touched a New 2-Week High of $2.98. The stock appeared on our News Catalysts scanner on Tue, Oct 25, 2022 at 06:49 PM in the 'INVESTOR UPDATE' category. From Tue, Oct 11, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days

About Taysha Gene Therapies Inc. (TSHA:NASDAQ)

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.